Key facts
- This page summarizes James Vincent Lambert's Form 3 filing for PRECIGEN, INC. (PGEN).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 21 Jun 2021, 20:47.
James Vincent Lambert - 10 Jun 2021 Form 3 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- Ex. Dir. Fin., PGEN Ther. Inc.
- Issuer ticker
- PGEN
- Reported as of
- 10 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ James V. Lambert, by Donald P. Lehr, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
James Vincent Lambert filed Form 3 for PRECIGEN, INC. (PGEN) on 21 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGEN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,356
- Date
- 10 Jun 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
holding
Derivative
Option to Purchase Common Stock (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $22.56
- Footnotes
- F1
PGEN
holding
Derivative
Option to Purchase Common Stock (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $8.17
- Footnotes
- F2
PGEN
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,170
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The stock options are fully vested.
Footnote F2
The stock options vest in equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025.
Footnote F3
The restricted stock units ("RSUs") vest in full on January 2, 2022.
Footnote F4
Each RSU represents a contingent right to receive one share of Precigen Common Stock.